Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Moodys
Boehringer Ingelheim
Baxter
Mallinckrodt

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Drug Price Trends for FONDAPARINUX

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for FONDAPARINUX

Average Pharmacy Cost for FONDAPARINUX

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
FONDAPARINUX 7.5 MG/0.6 ML SYR 55111-0680-10 64.06952 ML 2019-06-19
FONDAPARINUX 7.5 MG/0.6 ML SYR 55150-0232-10 64.06952 ML 2019-06-19
FONDAPARINUX 7.5 MG/0.6 ML SYR 67457-0584-06 64.06952 ML 2019-06-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for FONDAPARINUX

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
FONDAPARINUX NA 5MG/0.4ML SYRINGE Mylan Institutional LLC 67457-0583-04 10X0.4ML 254.12 2019-01-01 - 2020-01-31 FSS
FONDAPARINUX NA 7.5MG/0.6ML SYRINGE Mylan Institutional LLC 67457-0584-06 10X0.6ML 268.21 2019-01-01 - 2020-01-31 FSS
FONDAPARINUX NA 10MG/0.8ML SYRINGE Mylan Institutional LLC 67457-0585-08 10X0.8ML 279.11 2019-01-01 - 2020-01-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Mallinckrodt
Boehringer Ingelheim
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.